| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000020026 |
| Receipt No. | R000021830 |
| Official scientific title of the study | The effect of components in brown algae on prevention of life style related diseases, a randomized controlled trial. |
| Date of disclosure of the study information | 2015/12/02 |
| Last modified on | 2016/06/28 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | The effect of components in brown algae on prevention of life style related diseases, a randomized controlled trial. | |
| Title of the study (Brief title) | The effect of components in brown algae on prevention of life style related diseases. | |
| Region |
|
|
| Condition | ||
| Condition | Healthy adults | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | YES | |
| Objectives | |
| Narrative objectives1 | Anti-diabetic effect |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | HbA1c value on 8 weeks after intervention |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Intake of capsule including component in brown algae
1 capsule per day, 8 weeks |
|
| Interventions/Control_2 | Intake of capsule without component in brown algae
1 capsule per day, 8 weeks |
|
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Adults with 5.4-6.4% of HbA1c value | |||
| Key exclusion criteria | Some one who has been diagnosed diabetes or during treatment of diabetes.
Some one who has allergy for seaweed. Some one who is pregnant, breastfeeding or possibly pregnant. |
|||
| Target sample size | 120 | |||
| Research contact person | |
| Name of lead principal investigator | Nana Mikami |
| Organization | Sapporo Medical University |
| Division name | School of Medicine |
| Address | South-1, West-17, Chuo-ku, Sapporo, Hokkaido |
| TEL | 011-611-2111 |
| mikami7@sapmed.ac.jp | |
| Public contact | |
| Name of contact person | Nana Mikami |
| Organization | Sapporo Medical University |
| Division name | School of Medicine |
| Address | South-1, West-17, Chuo-ku, Sapporo, Hokkaido |
| TEL | 011-611-2111 |
| Homepage URL | |
| mikami7@sapmed.ac.jp | |
| Sponsor | |
| Institute | Sapporo Medical Unversity |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | MEXT |
| Organization | |
| Division | |
| Category of Funding Organization | |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021830 |